This analysis examines the current position and future outlook for Genzyme in the biotechnology sector. The profile encompasses company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.

• Benchmark Genzyme's performance against key rivals in the biotechnology sector
• Understand the impact of Genzyme's M&A strategy
• Understand the drivers of Genzyme's forecast double digit growth to 2010